Nuclear Medicine Equipment Market by Product, Application & by End user - Global Forecasts to 2020

Over the years, the nuclear medicine equipment market has witnessed various advancements in products and their approvals to meet the needs of patients and the radiologists. These advancements have led to the improved use of many existing nuclear medicine equipment as well as the introduction of some new ones.
In 2015, the SPECT systems are expected to account for the largest share of nuclear medicine equipment market, by product; in the SPECT segment the hybrid SPECT systems are likely to command the largest share and are expected to grow at a highest CAGR during the forecast period. Cardiology application segment is expected to account for the largest share of the global nuclear medicine equipment market, by application; the hospitals segment is expected to account for the largest share of the global nuclear medicine equipment market, by end user. Increased adoption of nuclear imaging equipment by hospitals around the world is a major factor for the large share hospitals in the global nuclear medicine equipment market.
In 2015, North America is expected to account for the largest share of the global nuclear medicine equipment market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the nuclear medicine equipment market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in this region can be attributed to increasing research and development investments, expansion of international players and increasing disease burden and favorable regulatory framework.
The global nuclear medicine equipment market is witnesses’ high competitive intensity with Siemens Healthcare (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.K.) being the market leaders. Other players include Mediso Medical Imaging Systems, Ltd. (Hungary), Toshiba Medical Systems Corporation (Japan), DDD-Diagnostics A/S (Denmark), Neusoft Medical Systems Co. Ltd. (China), SurgicEye GmbH (Germany), and CMR Naviscan Corporation (U.S.), among others. The players in this market have implemented various strategies to expand their global footprint and increase their market share. The key strategies followed by most of the companies in the nuclear medicine equipment include agreements/partnerships/alliances/collaborations; new product launches; expansions and others.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater markest share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.


The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nuclear medicine equipment market. The report analyzes the nuclear medicine equipment market, by product, application, and end user.

‧ Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, product approvals, and new product launches in the nuclear medicine equipment market

‧ Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various nuclear medicine equipment across regions

‧ Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the nuclear medicine equipment market

‧ Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nuclear medicine equipment market

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH METHODOLOGY STEPS 19
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.2.1 SECONDARY RESEARCH 20
2.2.1.1 Key data from secondary sources 20
2.2.2 PRIMARY RESEARCH 21
2.2.2.1 Key industry insights 22
2.2.2.2 Key data from primary sources 23
2.2.2.3 Key Insights from primary sources 24
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 27
2.5 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
3.1 CURRENT SCENARIO 29
3.2 FUTURE OUTLOOK 31
3.3 CONCLUSION 32
4 PREMIUM INSIGHTS 33
4.1 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET 33
4.2 NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION AND END USER 34
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 38
5.3.1.1 Introduction of new and advanced products 38
5.3.1.2 Investments through public-private partnerships to modernize diagnostic imaging centers 39
5.3.1.3 Advances in radiotracers 40
5.3.1.4 Increasing incidence and prevalence of cancer and cardiac ailments 40
5.3.1.5 Growing geriatric population 40
5.3.1.6 Increasing investments, funds, and grants by government bodies worldwide 41
5.3.2 RESTRAINTS 43
5.3.2.1 High cost of nuclear medicine equipment 43
5.3.2.2 Shorter half-life of radiopharmaceuticals 43
5.3.3 CHALLENGES 44
5.3.3.1 Increasing adoption of refurbished diagnostic imaging systems 44
5.3.3.2 Hospital budget cuts 44
5.3.4 OPPORTUNITIES 45
5.3.4.1 Strong product pipeline 45
5.3.4.2 High demand in emerging markets 46
6 NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT 47
6.1 INTRODUCTION 48
6.2 SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT) 50
6.2.1 STANDALONE SPECT SYSTEMS 51
6.2.2 HYBRID SPECT SYSTEMS 52
6.3 HYBRID PET 54
6.4 PLANAR SCINTIGRAPHY 55
7 NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION 56
7.1 INTRODUCTION 57
7.2 CARDIOLOGY 60
7.3 ONCOLOGY 61
7.4 NEUROLOGY 62
7.5 OTHER APPLICATIONS 63
8 NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER 64
8.1 INTRODUCTION 65
8.2 HOSPITALS 66
8.3 IMAGING CENTERS 67
8.4 ACADEMIC AND RESEARCH CENTERS 68
8.5 OTHER END USERS 69
?
9 NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION 70
9.1 INTRODUCTION 71
9.2 NORTH AMERICA 73
9.2.1 U.S. 77
9.2.1.1 Increased adoption of nuclear medicine equipment 77
9.2.1.2 Increase in the aging population and rising prevalence of chronic diseases 78
9.2.1.3 Declining reimbursements for radiology 78
9.2.1.4 Unfavorable healthcare reforms 78
9.2.2 CANADA 81
9.2.2.1 High incidence rate chronic diseases 81
9.3 EUROPE 84
9.3.1 EU5 88
9.3.1.1 Increasing number of PET-CT procedures in the U.K. 88
9.3.1.2 Increasing adoption of nuclear medicine equipment 88
9.3.1.3 Increasing incidence and prevalence of cancer 89
9.3.1.4 Increasing investment by stakeholders 89
9.3.1.5 Sluggish growth in healthcare expenditure 89
9.3.2 ROE 92
9.3.2.1 Government and public-private investments 92
9.3.2.2 Increased focus of market players 92
9.3.2.3 Rapid rise in the geriatric population 93
9.4 ASIA-PACIFIC (APAC) 95
9.4.1 JAPAN 99
9.4.1.1 Aging population and high healthcare expenditure in Japan 99
9.4.2 CHINA 102
9.4.2.1 Developing healthcare infrastructure 102
9.4.2.2 Rise in population, prevalence of diseases 102
9.4.2.3 Irregularities in the tendering process 102
9.4.3 INDIA 105
9.4.3.1 High incidence and prevalence of chronic diseases 105
9.4.3.2 Increasing installations of nuclear medicine equipment 105
9.4.3.3 Increasing focus of global market players 105
9.4.3.4 Improving healthcare insurance coverage 106
9.4.3.5 Increasing use of refurbished medical devices a major challenge for market players 106
9.4.4 REST OF ASIA-PACIFIC (ROAPAC) 108
9.4.4.1 Increasing incidence of chronic disease, growing geriatric population 108
9.4.4.2 Favorable regulatory changes in New Zealand and Australia 109
9.4.4.3 Increasing public-private investments 109
?
9.5 REST OF THE WORLD 112
9.5.1 LATIN AMERICA 113
9.5.1.1 Favorable reimbursement scenario in Brazil 113
9.5.1.2 Consolidation of healthcare service providers in Brazil 113
9.5.1.3 Growing healthcare infrastructure in Latin America 114
9.5.2 THE MIDDLE EAST 114
9.5.3 AFRICA 115
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
10.2 MARKET SHARE ANALYSIS 118
10.3 COMPETITIVE SITUATION AND TRENDS 120
10.3.1 NEW PRODUCT LAUNCHES 122
10.3.2 EXPANSIONS 124
10.3.3 ACQUISITIONS 125
10.3.4 OTHER STRATEGIES 126
11 COMPANY PROFILES 128

(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 128
11.2 PHILIPS HEALTHCARE 129
11.3 SIEMENS AG (SIEMENS HEALTHCARE) 132
11.4 GE HEALTHCARE 135
11.5 DIGIRAD CORPORATION 139
11.6 MEDISO MEDICAL IMAGING SYSTEMS LTD. 141
11.7 SURGICEYE GMBH 142
11.8 TOSHIBA MEDICAL SYSTEMS CORPORATION 144
11.9 DDD-DIAGNOSTIC A/S 146
11.10 NEUSOFT MEDICAL SYSTEMS CO., LTD. 147
11.11 CMR NAVISCAN CORPORATION 149

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
?
12 APPENDIX 150
12.1 DISCUSSION GUIDE 150
12.2 COMPANY DEVELOPMENTS (2012–2015) 155
12.2.1 PHILIPS HEALTHCARE 155
12.2.2 SIEMENS HEALTHCARE 156
12.2.3 GE HEALTHCARE 157
12.2.4 DIGIRAD CORPORATION 158
12.2.5 TOSHIBA MEDICAL SYSTEMS CORPORATION 158
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 159
12.4 AVAILABLE CUSTOMIZATIONS 159
12.5 RELATED REPORTS 160